MALAT1 and neoplasm: In addition to rs3200401, MALAT1 rs619586 polymorphisms presented significant differences in terms of clinical stage (AOR: 1.358-fold; 95% CI: 1.009~1.827; p=0.044) and tumor size (AOR: 1.429-fold; 95% CI: 1.064~1.919; p=0.018) in OSCC patients with at least one minor allele (AG or GG) (Table 4).